The Ioniq 5 XRT EV is a lot of fun off-pavement, if not ready for all that a rally stage or off-road trail might throw at it.

She’s had two healthy pregnancies since undergoing the trial, which uses modified white blood cells to attack cancer cells. Doctors believe she's the longest-surviving cancer patient to have received ...

Regeneron initiated a quarterly dividend per share that looks somewhat attractive. Despite some recent issues, the biotech ...

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results ...

The FDA has granted a fast track designation to rezpegaldesleukin for treating patients aged 12 years and older with moderate ...

Vishvaa Rajakumar won the Memory League World Championship, which tests memorization skills. He shared some of his techniques ...

RARE reports mixed fourth-quarter results, as earnings miss estimates while revenues beat the same. Product sales increase year over year.

Uber stock gained a second straight day as Bill Ackman said he had built a stake worth more than $2 billion. Trump's "America ...

"Tumor stem cells represent only 5% to 10% of the tumor, but they're the critical cells ... a molecule never before known to be involved in brain or other cancers. Along the way, Jackson, Pardoll and ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...